Insulin resistance (IR) is strongly associated with obesity and often coexists with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD) and is characterized by elevated circulating levels of insulin, glucose, and triglycerides. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.